Home
/ Iconovo
/ Competitors

Iconovo Competitors and Similar CompaniesClear all

Iconovo's competitors and similar companies include Cosmo Pharmaceuticals, Kaken Pharmaceutical, TRB Chemedica and Nippon Chemiphar.

	Iconovo Iconovo is a company that offers the development of inhalation products: inhaler devices and dry powder formulations.	Cosmo Pharmaceuticals Cosmo Pharmaceuticals is a company that focuses on solutions in the areas of astroenterology and endoscopy.	Kaken Pharmaceutical Kaken Pharmaceutical is a company providing pharmaceuticals and medical devices in the orthopedics and dermatology fields.	TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.	Nippon Chemiphar Nippon Chemiphar is a pharmaceutical company that specializes in the development of generic drugs.
Founding Date	Founding Date 2013	Founding Date 1997	Founding Date 1948	Founding Date 1980	Founding Date 1950
Type	Type Public	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma	Tags Healthcare biotech drug development medical devices pharma
Locations	Locations Lund, SE HQ	Locations Dublin, IE HQ	Locations Bunkyo City, JP HQ	Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more	Locations Chiyoda City, JP HQ Fukuoka, JP Osaka, JP Saitama, JP Sapporo, JP Sendai, JP
Employees	Employees 26	Employees 321	Employees 1,135	Employees 900	Employees 887
Valuation ($)	Valuation ($) 8.1 m	Valuation ($) N/A	Valuation ($) 961.7 m	Valuation ($) N/A	Valuation ($) 34.7 m
Financial
Revenue (est.)	Revenue (est.) kr1.1m (FY, 2025)	Revenue (est.) €104.2m (FY, 2025)	Revenue (est.) ¥94b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ¥32.6b (FY, 2025)
Cost of goods	Cost of goods kr3m (FY, 2025)	Cost of goods €40.4m (FY, 2025)	Cost of goods ¥33.2b (FY, 2025)	Cost of goods N/A	Cost of goods ¥22.4b (FY, 2025)
Gross profit	Gross profit (kr1.2m) (FY, 2025)	Gross profit €70.9m (FY, 2025)	Gross profit ¥60.8b (FY, 2025)	Gross profit N/A	Gross profit ¥10.1b (FY, 2025)
Net income	Net income (kr43.4m) (FY, 2025)	Net income (€3.5m) (FY, 2025)	Net income ¥13.9b (FY, 2025)	Net income N/A	Net income ¥294m (FY, 2025)